Clinician's Roundtable

Monkeypox continues to spread around the globe, and its clinical manifestations can differ from what we’ve seen. What are the newest symptoms of this disease? Learn more about these manifestations from Drs. Aatish Patel and Julia Bilinska from Guy's and St. Thomas' NHS Foundation Trust in London as they talk about their research with Mario Nacinovich.

Chronic rhinosinusitis, atopic dermatitis, and eosinophilic esophagitis are three of the most common comorbidities associated with eosinophilic asthma. So how can we factor those and other comorbidities—along with a patient’s goals and preferences—into our treatment plans for eosinophilic asthma? Joining Dr. Jennifer Caudle to share their perspectives are Drs. Ian Pavord and Praveen Akuthota.

Tools like MCED can help us detect cancer early, but how can we implement it in practice? Dr. Charles Turck joins Dr. Vershalee Shukla, a board-certified radiation oncologist and co-founder of the Vincere Cancer Center to discuss the clinical implementation of multi-cancer early detection screening.

The treatment landscape for eosinophilic asthma is a rapidly changing field, with new therapies arriving on a regular basis. One of the newer therapeutic approaches available is biologics. But how do they work to treat eosinophilic asthma? And which of our patients should be prescribed biologics and when? Tune in to hear Dr. Ian Pavord answer those and other key questions about the role of biologics in the eosinophilic asthma treatment landscape with Dr. Charles Turck.

Eosinophils are part of a complex set of allergic mechanisms in eosinophilic asthma. But eosinophils are far from the only component or driver of disease. Here to share key insights on the role of eosinophils along with genetic and environmental factors in the pathophysiology of eosinophilic asthma is pulmonary and critical care physician Dr. Praveen Akuthota.

As monkeypox continues to spread across non-endemic countries, how can we detect it in our patients? And what’s being done to stop the spread? Guest and fellow ReachMD Host Dr. Randy Young, a pulmonary disease and critical care medicine physician, joins Dr. John Russell to discuss what physicians should be looking for and how this virus has impacted public health.

Screening for alpha-1 antitrypsin deficiency in patients with chronic obstructive pulmonary disease (COPD) plays an integral role in modern care algorithms. But screening is only the first step, however, as primary care physicians and pulmonologists must then work together to coordinate a patient’s care. Joining Dr. Charles Turck to share their perspectives on how we can better collaborate to detect and treat alpha-1 in patients with COPD are primary care physician Dr. Brian Smith and pulmonologist Dr. Charlie Strange.

Click here to order free AlphaID™ screening kits to rule out alpha-1 deficiency in your patients.

Monkeypox is not something we’re used to seeing in non-endemic countries like North America and Europe. Yet its spreading has some experts scratching their heads. Dr. Amesh Adalja, a Senior Scholar at the Johns Hopkins Center for Health Security at the Bloomberg School of Public Health, shares with Dr. John Russell what clinicians need to know about monkeypox amid the global outbreak in non-endemic countries.

Since alpha-1 antitrypsin deficiency is prevalent among patients with chronic obstructive pulmonary disease (COPD), screening for alpha-1 is absolutely critical. However, diagnosing alpha-1 in patients with COPD can be challenging. That’s why pulmonologist and critical care specialist Dr. David Mares is here to share how we can overcome those challenges and the impact screening for alpha-1 may have on our patients with COPD.

Click here to order free AlphaID™ screening kits to rule out alpha-1 deficiency in your patients.

Primary care physicians play a critical role in screening for alpha-1 antitrypsin deficiency in patients with chronic obstructive pulmonary disease (COPD). But who should they be screening, and how? And what are some of the diagnostic challenges they should be aware of? Here to help answer those and other key questions for primary care physicians is Dr. Brian Smith, who’s in private practice at Versailles Family Medicine in Kentucky.

Click here to order free AlphaID™ screening kits to rule out alpha-1 deficiency in your patients.